NCT06689878Recruiting
Mobile Cognitive Behavioral Therapy for Stroke
Source: ClinicalTrials.gov · Last updated 4 Aug 2026
Brief summary (registry, in English)
This study aims to assess the feasibility and acceptability of "MAYA", a mobile cognitive behavioral therapy app for anxiety and mood disorders, in adults who have had a stroke.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- First submitted
- 13 Nov 2024
- Start date
- 25 Feb 2025
- Primary completion date
- Mar 2028
- Lead sponsor
- Weill Medical College of Cornell University
- Diseases
- Stroke
- NCT number
- NCT06689878
What you commit to
- Study type: Interventional
- Planned participants: 10
- From 25 Feb 2025 to the primary completion date, Mar 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of a bipolar or psychotic disorder
- Current alcohol or substance use disorder
- Severe depression and/or anxiety based on the initial evaluation and clinical judgment of the study doctor, which warrants a higher level of care and/or immediate referral to psychiatric services
Other
- Aphasia of moderate or greater severity (as determined during an eligibility evaluation)
- Non-fluency in English
- Active suicidal ideation
- Current engagement in psychotherapy is not grounds for exclusion unless the individual's psychotherapy is primarily focused on CBT
- Any other clinical or medical reason in the study doctor's initial screening evaluation that suggests the study is not appropriate for the participant
Who the study is looking for
- Age 40-79
- Presence of clinically-significant anxiety and/or depression (as determined by an eligibility evaluation)
- Stroke that occurred 1 month or more prior to study initiation
- Capacity to provide consent
- No greater than mild cognitive difficulties based on an eligibility evaluation conducted as part of the study
- If taking medication for depression and/or anxiety, must be on a stable dose for a minimum of 8 weeks prior to study initiation
- Ability to use iPhone or iPad independently
- Home internet access
- Willingness to participate in the full study duration.
Age in the registry: 40 years to 79 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Weill Cornell Medicine Coordinator of this site? Confirm its status | New York | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.